Metabolic Immune Checkpoint

Immunometabolism, the intricate interplay between metabolic processes and the immune system, has emerged as an exciting research domain over the last decade. As immunotherapy becomes a significant therapeutic strategy in the oncology landscape, understanding the metabolic immune checkpoints could pave the way for more effective treatments. Among several targets of interest, Interleukin-4 Induced Gene 1 (IL4I1) holds considerable promise. Creative Biolabs delves into the function, mechanism, and therapeutic potential of IL4I1 in battling diseases such as cancer.